IBDEI1A4 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22661,1,4,0)
 ;;=4^599.71
 ;;^UTILITY(U,$J,358.3,22661,1,5,0)
 ;;=5^Hematuria, Gross
 ;;^UTILITY(U,$J,358.3,22661,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,22662,0)
 ;;=599.72^^125^1395^22
 ;;^UTILITY(U,$J,358.3,22662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22662,1,4,0)
 ;;=4^599.72
 ;;^UTILITY(U,$J,358.3,22662,1,5,0)
 ;;=5^Hematuria, Microscopic
 ;;^UTILITY(U,$J,358.3,22662,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,22663,0)
 ;;=596.89^^125^1395^12
 ;;^UTILITY(U,$J,358.3,22663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22663,1,4,0)
 ;;=4^596.89
 ;;^UTILITY(U,$J,358.3,22663,1,5,0)
 ;;=5^Cystocele
 ;;^UTILITY(U,$J,358.3,22663,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,22664,0)
 ;;=596.81^^125^1395^15
 ;;^UTILITY(U,$J,358.3,22664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22664,1,4,0)
 ;;=4^596.81
 ;;^UTILITY(U,$J,358.3,22664,1,5,0)
 ;;=5^Cystostomy Infection
 ;;^UTILITY(U,$J,358.3,22664,2)
 ;;=^340556
 ;;^UTILITY(U,$J,358.3,22665,0)
 ;;=596.82^^125^1395^13
 ;;^UTILITY(U,$J,358.3,22665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22665,1,4,0)
 ;;=4^596.82
 ;;^UTILITY(U,$J,358.3,22665,1,5,0)
 ;;=5^Cystostomy Complication,Mechanical
 ;;^UTILITY(U,$J,358.3,22665,2)
 ;;=^340557
 ;;^UTILITY(U,$J,358.3,22666,0)
 ;;=596.83^^125^1395^14
 ;;^UTILITY(U,$J,358.3,22666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22666,1,4,0)
 ;;=4^596.83
 ;;^UTILITY(U,$J,358.3,22666,1,5,0)
 ;;=5^Cystostomy Complication,Other
 ;;^UTILITY(U,$J,358.3,22666,2)
 ;;=^340558
 ;;^UTILITY(U,$J,358.3,22667,0)
 ;;=788.91^^125^1395^60
 ;;^UTILITY(U,$J,358.3,22667,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22667,1,4,0)
 ;;=4^788.91
 ;;^UTILITY(U,$J,358.3,22667,1,5,0)
 ;;=5^Urinary Incontinence,Functional
 ;;^UTILITY(U,$J,358.3,22667,2)
 ;;=^336673
 ;;^UTILITY(U,$J,358.3,22668,0)
 ;;=788.99^^125^1395^64
 ;;^UTILITY(U,$J,358.3,22668,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22668,1,4,0)
 ;;=4^788.99
 ;;^UTILITY(U,$J,358.3,22668,1,5,0)
 ;;=5^Urinary System Symptoms,Other
 ;;^UTILITY(U,$J,358.3,22668,2)
 ;;=^273391
 ;;^UTILITY(U,$J,358.3,22669,0)
 ;;=626.9^^125^1396^32
 ;;^UTILITY(U,$J,358.3,22669,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22669,1,4,0)
 ;;=4^626.9
 ;;^UTILITY(U,$J,358.3,22669,1,5,0)
 ;;=5^Menstrual disorder
 ;;^UTILITY(U,$J,358.3,22669,2)
 ;;=^123887
 ;;^UTILITY(U,$J,358.3,22670,0)
 ;;=626.0^^125^1396^5
 ;;^UTILITY(U,$J,358.3,22670,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22670,1,4,0)
 ;;=4^626.0
 ;;^UTILITY(U,$J,358.3,22670,1,5,0)
 ;;=5^Amenorrhea
 ;;^UTILITY(U,$J,358.3,22670,2)
 ;;=Amenorrhea^5871
 ;;^UTILITY(U,$J,358.3,22671,0)
 ;;=628.0^^125^1396^6
 ;;^UTILITY(U,$J,358.3,22671,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22671,1,4,0)
 ;;=4^628.0
 ;;^UTILITY(U,$J,358.3,22671,1,5,0)
 ;;=5^Anovulatory cyclic bleeding
 ;;^UTILITY(U,$J,358.3,22671,2)
 ;;=^270583
 ;;^UTILITY(U,$J,358.3,22672,0)
 ;;=616.3^^125^1396^7
 ;;^UTILITY(U,$J,358.3,22672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22672,1,4,0)
 ;;=4^616.3
 ;;^UTILITY(U,$J,358.3,22672,1,5,0)
 ;;=5^Bartholin's abscess
 ;;^UTILITY(U,$J,358.3,22672,2)
 ;;=^12748
 ;;^UTILITY(U,$J,358.3,22673,0)
 ;;=610.0^^125^1396^10
 ;;^UTILITY(U,$J,358.3,22673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22673,1,4,0)
 ;;=4^610.0
 ;;^UTILITY(U,$J,358.3,22673,1,5,0)
 ;;=5^Breast, solitary cyst
 ;;^UTILITY(U,$J,358.3,22673,2)
 ;;=^112247
 ;;^UTILITY(U,$J,358.3,22674,0)
 ;;=610.1^^125^1396^23
 ;;^UTILITY(U,$J,358.3,22674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22674,1,4,0)
 ;;=4^610.1
 ;;^UTILITY(U,$J,358.3,22674,1,5,0)
 ;;=5^Fibrocystic breast disease
 ;;^UTILITY(U,$J,358.3,22674,2)
 ;;=^46167
 ;;
 ;;$END ROU IBDEI1A4
